These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 38985632)
21. Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients. Stam-Slob MC; Visseren FL; Wouter Jukema J; van der Graaf Y; Poulter NR; Gupta A; Sattar N; Macfarlane PW; Kearney PM; de Craen AJ; Trompet S Clin Res Cardiol; 2017 Jan; 106(1):58-68. PubMed ID: 27554244 [TBL] [Abstract][Full Text] [Related]
22. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society. Lyon AR; Dent S; Stanway S; Earl H; Brezden-Masley C; Cohen-Solal A; Tocchetti CG; Moslehi JJ; Groarke JD; Bergler-Klein J; Khoo V; Tan LL; Anker MS; von Haehling S; Maack C; Pudil R; Barac A; Thavendiranathan P; Ky B; Neilan TG; Belenkov Y; Rosen SD; Iakobishvili Z; Sverdlov AL; Hajjar LA; Macedo AVS; Manisty C; Ciardiello F; Farmakis D; de Boer RA; Skouri H; Suter TM; Cardinale D; Witteles RM; Fradley MG; Herrmann J; Cornell RF; Wechelaker A; Mauro MJ; Milojkovic D; de Lavallade H; Ruschitzka F; Coats AJS; Seferovic PM; Chioncel O; Thum T; Bauersachs J; Andres MS; Wright DJ; López-Fernández T; Plummer C; Lenihan D Eur J Heart Fail; 2020 Nov; 22(11):1945-1960. PubMed ID: 32463967 [TBL] [Abstract][Full Text] [Related]
23. Development and Validation of a Risk Score Model for Predicting the Cardiovascular Outcomes After Breast Cancer Therapy: The CHEMO-RADIAT Score. Kim DY; Park MS; Youn JC; Lee S; Choi JH; Jung MH; Kim LS; Kim SH; Han S; Ryu KH J Am Heart Assoc; 2021 Aug; 10(16):e021931. PubMed ID: 34369199 [TBL] [Abstract][Full Text] [Related]
24. Cardiovascular Risk Assessment and Prevention Across the Life Course: Propensity, Determinants, Risk, Disease. Lloyd-Jones DM; Wilkins JT J Am Coll Cardiol; 2023 Feb; 81(7):633-635. PubMed ID: 36792278 [No Abstract] [Full Text] [Related]
25. Urinary metabolic signatures reflect cardiovascular risk in the young, middle-aged, and elderly populations. Martinez PJ; Agudiez M; Molero D; Martin-Lorenzo M; Baldan-Martin M; Santiago-Hernandez A; García-Segura JM; Madruga F; Cabrera M; Calvo E; Ruiz-Hurtado G; Barderas MG; Vivanco F; Ruilope LM; Alvarez-Llamas G J Mol Med (Berl); 2020 Nov; 98(11):1603-1613. PubMed ID: 32914213 [TBL] [Abstract][Full Text] [Related]
26. [Cardiovascular complications of cancers and anti-cancer therapy]. Vyskočil J; Petráková K; Jelínek P; Furdek M Vnitr Lek; 2017; 63(3):200-209. PubMed ID: 28379023 [TBL] [Abstract][Full Text] [Related]
27. Exploratory Review of the Role of Statins, Colchicine, and Aspirin for the Prevention of Radiation-Associated Cardiovascular Disease and Mortality. Camara Planek MI; Silver AJ; Volgman AS; Okwuosa TM J Am Heart Assoc; 2020 Jan; 9(2):e014668. PubMed ID: 31960749 [No Abstract] [Full Text] [Related]
29. [Benefits of hypertension treatment in the elderly]. Girerd X; Hanon O Ann Cardiol Angeiol (Paris); 1999 Sep; 48(7):518-22. PubMed ID: 12555376 [TBL] [Abstract][Full Text] [Related]
30. Breast cancer therapy-associated cardiovascular disease. Zagar TM; Cardinale DM; Marks LB Nat Rev Clin Oncol; 2016 Mar; 13(3):172-84. PubMed ID: 26598943 [TBL] [Abstract][Full Text] [Related]
31. Cancer treatments may harm the heart. Doctors strive to prevent the cure for one disease from causing another. Harv Heart Lett; 2012 Aug; 22(12):1, 7. PubMed ID: 23025017 [No Abstract] [Full Text] [Related]
33. Secondary prevention of arterial disease in very elderly people: results from a prospective registry (FRENA). López-Jiménez L; Camafort M; Tiberio G; Carmona JA; Guijarro C; Martínez-Peñalver F; Monreal M; Angiology; 2008; 59(4):427-34. PubMed ID: 18388061 [TBL] [Abstract][Full Text] [Related]
34. Kidney cancer in the elderly. Kirkali Z Urol Oncol; 2009; 27(6):673-6. PubMed ID: 19879478 [TBL] [Abstract][Full Text] [Related]
35. Mitigating Cardiovascular Dysfunction Across the Cancer Continuum. Shelburne NM; Hammer MJ Oncol Nurs Forum; 2018 Jan; 45(1):15-17. PubMed ID: 29251286 [TBL] [Abstract][Full Text] [Related]
36. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Yeh ET; Tong AT; Lenihan DJ; Yusuf SW; Swafford J; Champion C; Durand JB; Gibbs H; Zafarmand AA; Ewer MS Circulation; 2004 Jun; 109(25):3122-31. PubMed ID: 15226229 [TBL] [Abstract][Full Text] [Related]
37. Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors. Schmitz KH; Prosnitz RG; Schwartz AL; Carver JR Cancer; 2012 Apr; 118(8 Suppl):2270-6. PubMed ID: 22488701 [TBL] [Abstract][Full Text] [Related]
38. Educational paper: decreasing the burden of cardiovascular disease in childhood cancer survivors: an update for the pediatrician. Dillenburg RF; Nathan P; Mertens L Eur J Pediatr; 2013 Sep; 172(9):1149-60. PubMed ID: 23361962 [TBL] [Abstract][Full Text] [Related]
40. Common Cardiovascular Complications of Cancer Therapy: Epidemiology, Risk Prediction, and Prevention. Narayan V; Ky B Annu Rev Med; 2018 Jan; 69():97-111. PubMed ID: 29414258 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]